This brand name is authorized in Finland, Lithuania
The drug JODIX contains one active pharmaceutical ingredient (API):
|
1
Potassium iodide
UNII 1C4QK22F9J - POTASSIUM IODIDE
|
|
Potassium iodide is indicated as a thyroid-blocking agent to prevent the uptake of radioactive iodine, for example after a nuclear accident or during a nuclear medicine investigation before administering a radioiodinated compound, which is metabolised to iodide or which contains radioiodine impurities. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V03AB21 | Potassium iodide | V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 012104, 012237 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1091271 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
